A Randomized, open-label, Phase 2 Study of Adjuvant Apalutamide or Standard of Care in Subjects with High-risk, Localized or Locally Advanced Prostate Cancer After Radical Prostatectomy (ADAM)
Basic data for this project
Type of project: Own resources project
Duration at the University of Münster: since 01/01/2020